GeoVax and Enesi Pharma to Collaborate on Development of Multiple Vaccines Administered by ImplaVax®, a Novel Needle-Free Vaccine Delivery Platform
02 janv. 2019 07h30 HE
|
GeoVax, Inc.
Potential for Addressing Multiple Infectious Disease Targets ATLANTA, GA and OXFORD, UK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a...